Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 30 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II/III Chemotherapy with Streptozotocin plus 5-FU or ADR vs Chlorozotocin for Metastatic, Unresectable, or Recurrent Primary Islet Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				EST-3278 EST-3278

Last Modified: 7/6/2007


2.		Phase II-III FAM (5-FU/ADR/MITO) vs V-FAM (FAM/VCR) vs Phase II Agent Chemotherapy for Advanced Gastric Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				SWOG-7841


3.		Phase II-III Chemotherapy with MeGAG or CLZ or AMSA or CTX/VCR/MTX for Colorectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				EST-1277R


4.		Phase I/II Systemic Hyperthermia plus Chemotherapy with Chlorozotocin for Unresectable Refractory Adult Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 to 69								NCI-D81-043-374


5.		Phase II Chemotherapy with Chlorozotocin for Advanced Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MSKCC-7793


6.		Phase II Chlorozotocin for Carcinoma of the Breast and Ovary, Melanoma, Islet Cell Carcinoma, Lymphoma, Sarcoma, and Other Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								NCI-78-C-97 NCI-MB-8402

Last Modified: 5/3/2006


7.		Phase II Adjuvant Chemotherapy with CLZ, TZT, CACP, or BCNU/5-FU for Intracranial Neoplasms

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 15								BTSG-7820


8.		Phase II Study of CLZ and PRED in the Treatment of Refractory Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								SEG-80MM265


9.		Phase II Chemotherapy with Chlorozotocin for Small Cell, Large Cell, Adenocarcinoma of Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-7832


10.		Phase II Chemotherapy with Chlorozotocin for Adenocarcinoma of the Colon, Pancreas, Liver, or Stomach

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-7833

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute